Key facts
- It has raised $37.6M; the latest was Secondary Transaction - Private ($9.6M) in Oct 2025.
- Notable investors include Gates Foundation, Impact Fund Denmark, Ohara, AAIC Investment, Alta Semper Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for MyDawa
- ·The full record, as it builds
Funding rounds
No funding rounds for MyDawa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MyDawa
Operator of an online pharmacy platform intended to connect patients to drug stores. The company offers medicines, health, and wellness products and does not charge any service fees, transaction, or delivery costs, enabling consumers to get products at affordable prices while eliminating the challenges faced in the pharmaceutical supply chain.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Nairobi, Kenya
- Founded
- 2015
- Employees
- 40
- Website
- mydawa.com/
- Ownership
- Privately Held (backing)
MyDawa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MyDawa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MyDawa in its N-PORT filings yet. We sweep new filings monthly.